Skip to content

Telemonitored Exercise to Attenuate Metabolic Dysregulation in Spinal Cord Injury

Telemonitored Exercise to Attenuate Metabolic Dysregulation in Spinal Cord Injury (TEAM-SCI)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05597176
Acronym
TEAM-SCI
Enrollment
4
Registered
2022-10-27
Start date
2023-01-13
Completion date
2025-01-24
Last updated
2025-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Injuries

Brief summary

The purpose of this research is to test the health benefits of using functional electrical stimulation for lower extremity exercise at home.

Detailed description

The specific objectives are to assess the impact of 16 weeks of home-based telemonitored functional electrical stimulation leg cycle ergometry (FESLCE) exercise on body composition and metabolic health in adults with C4-T4 motor complete SCI. This study is available only to those who were previously enrolled in the SCIENCE protocol #20190659 that were randomized to the diet alone group. After completing the dietary intervention, those individuals will have an opportunity to experience FES bicycle.

Interventions

OTHERSpinal Cord Injury Exercise Group

Participants will have an initial accommodation period of 4 weeks, during which four 10-minute exercise bouts/day will be interspersed with 5 minutes of rest. The bouts will gradually increase until at least continuous 40-minute sessions. The remaining 12-week intervention will be set at 70% max heart rate for a total of 16 weeks.

Sponsors

University of Miami
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Women of child-bearing potential who agree to refrain from getting pregnant during the trial * Previously enrolled in the SCIENCE protocol (NCT03495986) randomized to the diet alone group in SCIENCE, and are willing to complete an 8-week (2 month) washout period after the completion of the dietary intervention in the study.

Exclusion criteria

* Do not meet inclusion criteria above * Those who have participated in a Functional Electrical Stimulation (FES) or ACE exercise program (\>60 minutes/week) within the past 3 months * Self-reported or documented history of: * orthopedic limitations * coronary artery disease * type 1 diabetes mellitus; insulin-requiring Type 2 diabetes mellitus; untreated Type 2 diabetes mellitus * untreated hypothyroidism * renal disease * uncontrolled autonomic dysreflexia, recent (within 3 months) * deep vein thrombosis (within the past 3 months) * On anticoagulation therapy * Pressure injuries \> Grade II * Decisional impairment * Prisoners * Pregnant or nursing women * Any potential causes of autonomic dysreflexia at the discretion of the PI

Design outcomes

Primary

MeasureTime frameDescription
Change in percent body fatBaseline, 20 weeks (Post Intervention)Percent body fat will be assessed using Dual Energy x-ray absorbency (DXA)
Change in percent visceral fatBaseline, 20 weeks (Post Intervention)Percent visceral fat will be assessed using DXA
Change in percent of lean body massBaseline, 20 weeks (Post Intervention)Percent lean body mass will be assessed using DXA
Change in percent of fat free massBaseline, 20 weeks (Post Intervention)Percent fat free mass will be assessed using DXA

Secondary

MeasureTime frameDescription
Change in Insulin levelsBaseline, 20 weeks (Post Intervention)Insulin levels will be assessed using blood samples
Change in glucose levelsBaseline, 20 weeks (Post Intervention)Glucose will be measured in mg/dL using blood samples
Change in hsCRP levelsBaseline, 20 weeks (Post Intervention)High sensitivity C Reactive Protein (hsCRP) will be assessed using blood samples
Change in HgbA1C levelsBaseline, 20 weeks (Post Intervention)Hemoglobin A1c (HgbA1c) levels will be assessed using blood samples
Change in Lipid Panel valuesBaseline, 20 weeks (Post Intervention)Lipid panel values including High Density Lipoprotein, Low Density Lipoprotein, Total Cholesterol and triglycerides, all assessed in mg/dL, will be measured from blood samples
Change in resting metabolic rateBaseline, 20 weeks (Post Intervention)Change in resting metabolic rate will be measured by using a large clear plastic dome over the head and the air exhaled will be measured

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026